Director Technical Strategy and Quality, Pharmaceuticals and Health Technologies Group
David Lee Chin, M.D., is Director Technical Strategy and Quality for the Pharmaceuticals and Health Technologies Group. He has over 30 years of experience in pharmaceutical management, including training, operations research and evaluation, and providing technical assistance to enhance access to and rational use of medicines in Africa, Asia, and the Americas. Dr. Lee is responsible for technical strategy oversight of PHT projects and designing and managing pharmaceutical sector studies. In addition to his medical degree and residency in pediatrics, he is also trained in Clinical Pharmacology.
Helena Walkowiak is currently a Principal Technical Advisor with the Center for Pharmaceutical Management. She has seventeen years of experience in providing technical assistance in pharmaceutical management to health programs in Africa, Asia, Eastern Europe, and the Caribbean. Ms.
Dai Hozumi is Senior Director for Health Technologies. During his 20-year career in global health, he has worked in more than 20 countries, including Zambia, Malawi, Mexico, Pakistan, and Kenya. He holds an MD from Juntendo University, Japan, an MPH from the University of California at Berkeley, USA, and an MS in Management from the MIT Sloan School of Management, USA.
Andre Zagorski is senior principal technical advisor in MSH’s Pharmaceuticals and Health Technologies (PHT) Group, in charge of developing TB strategies and interventions to ensure universal access to anti-TB medicines, regimens and new technologies in line with the USAID and WHO goals of ending the TB epidemic.